Calamos Advisors’s Ocean Biomediacal, Inc. Warrants OCEAW Stock Holding History

Calamos Advisors’s Portfolio OCEAW Stock Details OCEAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62,500	Closed	-$1.67K	–	1003
2025 Q1	$1.67K	Hold	62,500	–	–	﹤0.01%	896
2024 Q4	$1.45K	Hold	62,500	–	–	﹤0.01%	892
2024 Q3	$3.06K	Hold	62,500	–	–	﹤0.01%	909
2024 Q2	$3.01K	Hold	62,500	–	–	﹤0.01%	921
2024 Q1	$18.3K	Hold	62,500	–	–	﹤0.01%	862
2023 Q4	$2.13K	Hold	62,500	–	–	﹤0.01%	899
2023 Q3	$9.46K	Hold	62,500	–	–	﹤0.01%	874
2023 Q2	$15.9K	Hold	62,500	–	–	﹤0.01%	893
2023 Q1	$17.5K	Hold	62,500	–	–	﹤0.01%	1017
2022 Q4	$9.22K	Hold	62,500	–	–	﹤0.01%	1111
2022 Q3	$13K	Buy	+62,500	New	+$8.21K	﹤0.01%	1149

Calamos Advisors's OCEAW Position: Q2 2025 in Review

Calamos Advisors sold out of Ocean Biomediacal, Inc. Warrants (OCEAW) in Q2 2025, closing a stake of 62,500 shares — an estimated $1.67K sold.

Calamos Advisors first reported a position in OCEAW in Q3 2022 and held it in 11 quarters. The position peaked at $18.3K in Q1 2024. 1 fund tracked by Wall St. Rank holds OCEAW as of Q2 2025.

Calamos Advisors reported no remaining Ocean Biomediacal, Inc. Warrants position as of Q2 2025 after selling out during the quarter.
Calamos Advisors sold 62,500 Ocean Biomediacal, Inc. Warrants shares in Q2 2025, an estimated $1.67K.
Calamos Advisors first reported a position in Ocean Biomediacal, Inc. Warrants in Q3 2022 and held it in 11 quarters.
Calamos Advisors's Ocean Biomediacal, Inc. Warrants position peaked at $18.3K in Q1 2024.
1 fund tracked by Wall St. Rank held Ocean Biomediacal, Inc. Warrants as of Q2 2025.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.